Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inti Zlobec

Showing results (101-110 of 260) with videos related to

Pageof 26
Sort By:
Human Pathology|September 10, 2015
Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancersViktor Hendrik Koelzer, Bettina Huber, Valentina Mele, et al.
Journal of Molecular Biology|September 7, 2023
WebSTR: A Population-wide Database of Short Tandem Repeat Variation in HumansOxana Sachenkova Lundström, Max Adriaan Verbiest, Feifei Xia, et al.
Virchows Archiv : an International Journal of Pathology|April 12, 2021
Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancerInti Zlobec, Melanie Bächli, Francesca Galuppini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 19, 2025
Prognostic Value of Tumor-Stroma Ratio in a Screened Stage II Colon Cancer Population: Intratumoral Site-Specific Assessment and Tumor Budding SynergyMaria Pihlmann Kristensen, Ulrik Korsgaard, Signe Timm, et al.
Virchows Archiv : an International Journal of Pathology|July 8, 2024
Immunohistochemical analysis of tumor budding in stage II colon cancer: exploring zero budding as a prognostic markerMaria Pihlmann Kristensen, Ulrik Korsgaard, Signe Timm, et al.
NPJ Precision Oncology|August 13, 2024
The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibitionHannah L Williams, Ana Leni Frei, Thibaud Koessler, et al.
Sensors (Basel, Switzerland)|May 14, 2025
Bridging Domain Gaps in Computational Pathology: A Comparative Study of Adaptation StrategiesJoão D Nunes, Diana Montezuma, Domingos Oliveira, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 10, 2006
Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancerAlessandro Lugli, Inti Zlobec, Ursula Günthert, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 17, 2012
The clinical impact of p16 status in fine-needle aspirates of cervical lymph node metastasis of head and neck squamous cell carcinomasJens Jakscha, Inti Zlobec, Claudio Storck, et al.
Histopathology|October 12, 2013
The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcomeHeather Dawson, Viktor H Koelzer, Eva Karamitopoulou, et al.
Pageof 26

Showing results (101-110 of 260) with videos related to

Sort By:
Pageof 26
Human Pathology|September 10, 2015
Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancersViktor Hendrik Koelzer, Bettina Huber, Valentina Mele, et al.
Journal of Molecular Biology|September 7, 2023
WebSTR: A Population-wide Database of Short Tandem Repeat Variation in HumansOxana Sachenkova Lundström, Max Adriaan Verbiest, Feifei Xia, et al.
Virchows Archiv : an International Journal of Pathology|April 12, 2021
Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancerInti Zlobec, Melanie Bächli, Francesca Galuppini, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 19, 2025
Prognostic Value of Tumor-Stroma Ratio in a Screened Stage II Colon Cancer Population: Intratumoral Site-Specific Assessment and Tumor Budding SynergyMaria Pihlmann Kristensen, Ulrik Korsgaard, Signe Timm, et al.
Virchows Archiv : an International Journal of Pathology|July 8, 2024
Immunohistochemical analysis of tumor budding in stage II colon cancer: exploring zero budding as a prognostic markerMaria Pihlmann Kristensen, Ulrik Korsgaard, Signe Timm, et al.
NPJ Precision Oncology|August 13, 2024
The current landscape of spatial biomarkers for prediction of response to immune checkpoint inhibitionHannah L Williams, Ana Leni Frei, Thibaud Koessler, et al.
Sensors (Basel, Switzerland)|May 14, 2025
Bridging Domain Gaps in Computational Pathology: A Comparative Study of Adaptation StrategiesJoão D Nunes, Diana Montezuma, Domingos Oliveira, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 10, 2006
Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancerAlessandro Lugli, Inti Zlobec, Ursula Günthert, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 17, 2012
The clinical impact of p16 status in fine-needle aspirates of cervical lymph node metastasis of head and neck squamous cell carcinomasJens Jakscha, Inti Zlobec, Claudio Storck, et al.
Histopathology|October 12, 2013
The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcomeHeather Dawson, Viktor H Koelzer, Eva Karamitopoulou, et al.
Pageof 26